, Volume 9, Issue 6, pp 401–405 | Cite as

New Antifungal Drugs

  • R. J. Holt
Guest Editorial


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    British Thoracic and Tuberculosis Association: Tubercle 51: 227 (1970).CrossRefGoogle Scholar
  2. 2.
    Summers, W.St.C: Amphotericin pharmacophobia. British Medical Journal 4: 460 (1973).CrossRefGoogle Scholar
  3. 3.
    Thienpoint, D.; Vamparijs, O.F.J.; Raeymaekers, A.H.M.; Vandenberk, J.; Demoen, P.J.A.; Allewijn, F.T.N.; Marsboom, R.P.H.; Niemegeers, C.J.E.; Schellekens, K.H.L. and Janssen, P.A.J.: Tetramisole (R8299): a new, potent broad spectrum anthelmintic. Nature 209: 1084 (1966).CrossRefGoogle Scholar
  4. 4.
    Mahgoub, ElS.: Laboratory and clinical experience with clotrimazole (Bay b 5097). Sabouraudia 10: 210 (1972).CrossRefGoogle Scholar
  5. 5.
    Schassen, H.-H.; Matz, K.; Freisenhausen, H.-O. and Harm, K.: Treatment of acute toxoplasmosis with clotrimazole (Bay b 5097). Cited in ref. 14.Google Scholar
  6. 6.
    Islam, N. and Hasan, M.: Tinidazole in the treatment of intestinal amoebiasis. Current Therapeutic Research 17: 161 (1975).PubMedGoogle Scholar
  7. 7.
    Bewick, M.: personal communication (1973).Google Scholar
  8. 8.
    Grunberg, E.; Titsworth, E. and Bennett, M.: Chemotherapeutic activity of 5-fluorocytosine. Antimicrobial Agents and Chemotherapy 3: 566 (1963).Google Scholar
  9. 9.
    Grunberg, E.; Prince, H.N. and Utz, J.F.: Observations on the activity of two newer antifungal agents Saramycin (X-5079c) and 5-fluorocytosine. Proceedings of the V International Congress of Chemotherapy; in Spitzy and Haschek Verlag der Wiener Med. Akad. 4: 69 (1967).Google Scholar
  10. 10.
    Koechlin, B.A.; Rubio, F.; Palmer, S.; Gabriel, T. and Duschinsky R.: The metabolism of 5-fluorocytosine-2 14C and of cytosine 14C in the rat and the disposition of 5-fluorocytosine-2 14C in man. Biochemical Pharmacology 15: 435 (1966).PubMedCrossRefGoogle Scholar
  11. 11.
    Shadomy, S.: In vitro studies with 5-fluorocytosine. Applied Microbiology 17: 871 (1969).PubMedGoogle Scholar
  12. 12.
    Shadomy, S.: Further in vitro studies with 5-fluorocytosine. Infect.Immun. 2: 484 (1970).PubMedGoogle Scholar
  13. 13.
    Holt, R.J. and Newman, R.L.: The antimycotic activity of 5-fluorocytosine. Journal of Clinical Pharmacology 26: 167(1973).Google Scholar
  14. 14.
    Holt, R.J.: Recent developments in antimycotic chemotherapy. Infection 2: 295 (1974).CrossRefGoogle Scholar

Copyright information

© Adis Press 1975

Authors and Affiliations

  • R. J. Holt
    • 1
  1. 1.Queen Mary’s Hospital for ChildrenCarshalton, SurreyEngland

Personalised recommendations